The Journal of Clinical Medicine retracts the article “Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?” [1], cited above.
Following publication, concerns were brought to the attention of the publisher regarding potential redundancy with a previous publication [2] from the same authorship group.
Adhering to our complaint’s procedure, an investigation was conducted by the Editorial Office and the Editorial Board that confirmed a significant overlap between the two publications. As a result, the Editorial Office and Editorial Board consider this publication [1] to be redundant, and therefore have decided to retract it as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30) and in line with the Committee on Publication Ethics’ retraction guidelines (https://publicationethics.org/retraction-guidelines).
This retraction was approved by the Editor-in-Chief of the Journal of Clinical Medicine.
The authors did not provide a comment on this retraction decision.
References
- De Vecchis, R.; Cantatrione, C.; Mazzei, D.; Baldi, C. RETRACTED: Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice? J. Clin. Med. 2016, 5, 86. [Google Scholar] [CrossRef] [PubMed]
- De Vecchis, R.; Cantatrione, C.; Mazzei, D. Vasopressin receptor antagonists in patients with chronic heart failure. Herz 2017, 42, 492–497. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).